AU;Current Trials
  • Home
  • Clinical Trials
  • Alopecia Areata Studies Kapiti 102

Alopecia Areata Study

Kapiti

Please note that this study has now closed. However, we encourage you to pre-register your interest for future alopecia studies here. 

Future Studies

Description

What to expect

Future Studies

Study details

Ages

18 to 60 years old (male) OR 18 to 75 years old (female)

Duration

The study will last up to 40 weeks with 13 in-person clinic visits

Compensation

Participants will be compensated up $4,200

Eligibility Criteria

You may qualify if you:

  • Are 18 to 60 years old (male) OR 18 to 75 years old (female)
  • Have severe to very severe Alopecia Areata with ≥50% hair loss of the scalp
  • Have had your current episode of hair loss for 7 years or less
  • Have had no signs of hair regrowth in the last 6 months

Other criteria applies. A member of our team will check if this study is a good fit for you.

Locations

Kapiti

Description

Alopecia Areata is an autoimmune condition where the body mistakenly attacks hair follicles, causing hair loss on the scalp or body. It can appear as small patches or, in more severe cases, result in total loss of scalp and/or body hair. While not physically harmful, it can have a significant impact on a person's self-esteem and quality of life. Living with alopecia areata can sometimes lead to feelings of anxiety and depression, showing why more effective treatment options are needed to support people in living with confidence each day.

Current treatments for Alopecia Areata, such as corticosteroids, immunotherapy and newer medications, can sometimes help regrow hair, but they are not effective for everyone, and relapses are common. 

This study is exploring a potential new treatment that target the immune pathways driving hair loss, aiming for safer and more effective solutions. Specifically, it is testing whether the investigational treatment, can promote hair regrowth, slow the progression of severe Alopecia Areata, and ultimately improve quality of life for people living with the condition.

What to expect

Participants will be randomly assigned to receive either the investigational treatment or a placebo. Treatment is given by intravenous infusion (IV) at regular clinic visits under the supervision of trained medical staff. 

Throughout the study, you will attend scheduled health assessments that include photography of the scalp to track hair growth, blood tests and thorough medical check-ups. These visits are designed to carefully monitor your progress and overall health. Your safety and well-being will always be our highest priority. An experienced clinical team available to answer questions, provide support, and ensure you feel comfortable and cared for at every stage of participation.

Why join a clinical research study? 

  • Gain early access to new potential treatments at no cost
  • Contribute to research that could make a difference for others living with Alopecia Areata
  • Receive health checks and advice from our professional medical team

Your privacy is important. All personal information will be kept strictly confidential.

Register your interest today.

This study is now closed

Please note that this study has now closed. However, we encourage you to pre-register your interest for future alopecia studies here. 

Alopecia Areata Studies
Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

WellingtonTaurangaKapitiPalmerston NorthDunedinPukekohe AucklandPCRN Clinical Trial Sites

Australian locations

Fortitude Valley BrisbaneTaringa BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2026 © Momentum Clinical Research

Privacy Policy